BC Week In Review | Dec 20, 2010
Company News

CytoGenix management update

CytoGenix Inc. (Pink:CYGX), Houston, Texas   Business: Functional genomics, Genomics   Resigned: Steven Plumb as CFO; and Cy Stein as president, CEO and a director  ...
BC Week In Review | Dec 20, 2010
Company News

CytoGenix functional genomics, genomics news

CytoGenix will negotiate with former employees Frank Vazquez and Lawrence Wunderlich to regain rights to IP related to undisclosed CytoGenix assets. The former employees gained rights to the asssets in summary judgment. CytoGenix also believes...
BioCentury | Dec 20, 2010
Emerging Company Profile

BigDNA: Fewer Shots on Goal

Most marketed HBV vaccines, as well as DNA vaccines in development for the disease, require multiple booster injections or an adjuvant to trigger an immune response. BigDNA Ltd. believes its bacteriophage-delivered DNA vaccine will require...
BC Week In Review | Sep 20, 2010
Company News

CytoGenix management update

CytoGenix Inc. (NASDAQ:CYGX), Houston, Texas   Business: Functional genomics, Genomics   Hired: Steven Plumb as CFO, formerly president of Clear Financial Solutions Inc.; he replaced Randy Moseley, who resigned as CFO and chairman  ...
BioCentury | May 4, 2009
Product Development

Opportunity in Crisis

The scramble to create and mass produce vaccines to combat the outbreak of H1N1 swine influenza is exposing the limitations of global pandemic preparedness and, in the process, highlighting scientific, technological and commercial opportunities for...
BC Innovations | Oct 9, 2008
Distillery Therapeutics

This Week in Therapeutics

This week in therapeutics Indication Target/marker/ pathway Summary Licensing status Publication and contact information Infectious disease Escherichia MurJ (MviN) Bioinformatics studies suggest that the bacterial membrane enzyme MurJ could be targeted to help treat infections....
BC Week In Review | Sep 17, 2007
Company News

CytoGenix management update

CytoGenix Inc. (CYGX), Houston, Texas   Business: Functional genomics, Genomics   Hired: Greg Taylor as CFO and VP of finance and administration while remaining managing director of Monterey Capital Partners LLC; he replaces interim CFO...
BC Week In Review | May 14, 2007
Company News

CytoGenix, Eurogentec deal

CYGX and Eurogentec signed a letter of intent to develop undisclosed products using CYGX's synDNA production technology. CYGX has preclinical synDNA vaccines against influenza, HIV/AIDS, smallpox and HBV. Further terms were not disclosed. CytoGenix Inc....
BC Week In Review | Apr 9, 2007
Clinical News

CytoGenix preclinical data

CYGX's synthetic DNA vaccine against avian influenza virus protected mice against a lethal challenge of virus. In contrast, all control animals died upon challenge. Complete data will be presented in May at the DNA Vaccine...
BC Week In Review | Dec 18, 2006
Clinical News

CytoGenix preclinical data

Monkeys injected with a synDNA HIV vaccine mounted a significant cellular immune response. The vaccine targets gag and env viral proteins and uses IL-15 as an adjuvant. CytoGenix Inc. (CYGX), Houston, Texas   Product: SynDNA...
Items per page:
1 - 10 of 38
BC Week In Review | Dec 20, 2010
Company News

CytoGenix management update

CytoGenix Inc. (Pink:CYGX), Houston, Texas   Business: Functional genomics, Genomics   Resigned: Steven Plumb as CFO; and Cy Stein as president, CEO and a director  ...
BC Week In Review | Dec 20, 2010
Company News

CytoGenix functional genomics, genomics news

CytoGenix will negotiate with former employees Frank Vazquez and Lawrence Wunderlich to regain rights to IP related to undisclosed CytoGenix assets. The former employees gained rights to the asssets in summary judgment. CytoGenix also believes...
BioCentury | Dec 20, 2010
Emerging Company Profile

BigDNA: Fewer Shots on Goal

Most marketed HBV vaccines, as well as DNA vaccines in development for the disease, require multiple booster injections or an adjuvant to trigger an immune response. BigDNA Ltd. believes its bacteriophage-delivered DNA vaccine will require...
BC Week In Review | Sep 20, 2010
Company News

CytoGenix management update

CytoGenix Inc. (NASDAQ:CYGX), Houston, Texas   Business: Functional genomics, Genomics   Hired: Steven Plumb as CFO, formerly president of Clear Financial Solutions Inc.; he replaced Randy Moseley, who resigned as CFO and chairman  ...
BioCentury | May 4, 2009
Product Development

Opportunity in Crisis

The scramble to create and mass produce vaccines to combat the outbreak of H1N1 swine influenza is exposing the limitations of global pandemic preparedness and, in the process, highlighting scientific, technological and commercial opportunities for...
BC Innovations | Oct 9, 2008
Distillery Therapeutics

This Week in Therapeutics

This week in therapeutics Indication Target/marker/ pathway Summary Licensing status Publication and contact information Infectious disease Escherichia MurJ (MviN) Bioinformatics studies suggest that the bacterial membrane enzyme MurJ could be targeted to help treat infections....
BC Week In Review | Sep 17, 2007
Company News

CytoGenix management update

CytoGenix Inc. (CYGX), Houston, Texas   Business: Functional genomics, Genomics   Hired: Greg Taylor as CFO and VP of finance and administration while remaining managing director of Monterey Capital Partners LLC; he replaces interim CFO...
BC Week In Review | May 14, 2007
Company News

CytoGenix, Eurogentec deal

CYGX and Eurogentec signed a letter of intent to develop undisclosed products using CYGX's synDNA production technology. CYGX has preclinical synDNA vaccines against influenza, HIV/AIDS, smallpox and HBV. Further terms were not disclosed. CytoGenix Inc....
BC Week In Review | Apr 9, 2007
Clinical News

CytoGenix preclinical data

CYGX's synthetic DNA vaccine against avian influenza virus protected mice against a lethal challenge of virus. In contrast, all control animals died upon challenge. Complete data will be presented in May at the DNA Vaccine...
BC Week In Review | Dec 18, 2006
Clinical News

CytoGenix preclinical data

Monkeys injected with a synDNA HIV vaccine mounted a significant cellular immune response. The vaccine targets gag and env viral proteins and uses IL-15 as an adjuvant. CytoGenix Inc. (CYGX), Houston, Texas   Product: SynDNA...
Items per page:
1 - 10 of 38